Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib vs. TACE-Sorafenib in HCC with Extrahepatic Metastasis
NCT03518502Phase 4Unknown
- Sponsor
- Korea University
- Start
- Mar 2012
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Korea University. Status: unknown.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03518502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03518502.